title: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.
abstract: Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of first-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.
authors.affiliation: Research Department of Infection, University College London, London, UK. d.pillay@ucl.ac.uk.
authors.forename: Deenan
authors.initials: D
authors.lastname: Pillay
authors.forename: Jan
authors.initials: J
authors.lastname: Albert
authors.forename: Silvia
authors.initials: S
authors.lastname: Bertagnolio
authors.forename: Charles
authors.initials: C
authors.lastname: Boucher
authors.forename: Francoise
authors.initials: F
authors.lastname: Brun-Vezinet
authors.forename: Bonaventura
authors.initials: B
authors.lastname: Clotet
authors.forename: Carlo
authors.initials: C
authors.lastname: Giaquinto
authors.forename: Carlo F
authors.initials: CF
authors.lastname: Perno
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003906:Developing Countries; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D006295:Health Resources; D006801:Humans
chemical_list: D019380:Anti-HIV Agents